Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

protagonist12

05/21/15 10:05 AM

Post #1

BOSTON--(BUSINESS WIRE)--Press Ganey Holdings, Inc. today announced the pricing of its initial public offering of 8,900,000 shares of common stock at a public offering price of $25.00 per share, before underwriting discounts. All of the common stock is being offered by Press Ganey. In addition, Press Ganey has granted the underwriters a 30-day option to purchase up to an additional 1,335,000 shares of common stock from the company at the public offering price. The company's shares are expected to begin trading on The New York Stock Exchange on May 21, 2015 under the ticker symbol "PGND."

Barclays Capital Inc. and Goldman, Sachs & Co. are acting as lead book-running managers for the offering. William Blair & Company, L.L.C. and Wells Fargo Securities, LLC are acting as additional book-runners. Raymond James & Associates, Inc., Robert W. Baird & Co., BMO Capital Markets Corp. and Avondale Partners, LLC are acting as co-managers.

Press Ganey Holdings (PGND)

Followers	1	Posters	1
Posts (Today)	0	Posts (Total)	1
Created	05/21/15	Type	Free
Moderators

Press Ganey is a leading provider of patient experience measurement, performance analytics and strategic advisory solutions for healthcare organizations across the continuum of care. Our mission is to help healthcare organizations reduce patient suffering and improve clinical quality, safety and the patient experience. We provide our clients with innovative, technology-based solutions that capture the perspectives of patients, physicians, nurses and other healthcare employees, which enable our clients to benchmark, analyze and improve the patient's care experience. We support clients in achieving the "Triple Aim" of improving the patient experience, managing their population's health and controlling costs through improved patient engagement and experience of care. We believe we offer a powerful value proposition to the healthcare industry, as we help drive transformational change through greater performance transparency, better care coordination and sustainable performance improvements.